◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

GLOBAL MEDICAL REIT INC.

CIK: 1533615 SIC: 6798
$148.21M
Revenue
$-6.88M
Net Income
-
Gross Margin
-
Op. Margin
$120.29M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 10 of 12 annual reports available (2012 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
+ Total Revenue $148.21M $148.21M $138.78M $141.05M $137.28M $115.94M $93.73M $70.73M $53.19M $30.34M $8.21M
Revenue Growth % 0.0% 6.8% -1.6% 2.7% 18.4% 23.7% 32.5% 33.0% 75.3% 269.6% nan%
Operating Expenses - - - $134.01M $124.04M $98.66M $96.23M $61.14M $46.31M $30.43M $14.56M
Interest Expense $48.68M $27.78M $26.57M $30.89M $25.23M $19.70M $18.68M $17.47M $14.97M $7.43M $4.14M
+ Net Income $-6.88M $-6.88M $6.69M $21.73M $20.00M $18.34M $-2.50M $9.59M $14.56M $-87.00K $-6.35M
Net Margin % -4.6% -4.6% 4.8% 15.4% 14.6% 15.8% -2.7% 13.6% 27.4% -0.3% -77.4%
Basic EPS -0.99 -0.91 0.06 1.13 0.20 0.19 -0.17 0.10 nan nan nan
Diluted EPS nan -0.91 0.06 1.13 0.20 0.19 -0.17 0.10 nan nan nan
Basic Shares Outstanding - 13.4M 13.2M 13.1M 65.5M 60.6M 46.3M 33.9M - - -
Diluted Shares Outstanding - 13.4M 13.2M 13.1M 65.5M 60.6M 46.3M 33.9M - - -
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
Cash & Cash Equivalents $9.08M $6.82M $1.28M $4.02M $7.21M $5.51M $2.77M $3.63M $5.11M $19.67M
Accounts Receivable $7.22M $7.42M $6.76M $8.04M $6.07M $5.60M $4.96M $2.90M $704.00K $212.44K
Goodwill $5.90M $5.90M $5.90M $5.90M $5.90M $5.90M - - - -
Intangible Assets $46.00M $53.70M - - - - - - - $7.14M
Other Non-current Assets - - - $6.55M $6.23M $5.02M $3.59M $322.00K $459.00K $140.37K
Total Assets $1.24B $1.26B $1.27B $1.39B $1.26B $1.10B $884.93M $636.10M $474.57M $227.32M
Long-term Debt $1.15M - - - - - - - - -
Total Liabilities $712.40M $700.57M $661.89M $744.20M $625.91M $643.15M $424.58M $336.35M $215.56M $72.29M
Common Stock $13.00K $13.00K $66.00K $66.00K $65.00K $49.00K $44.00K $26.00K $22.00K $17.61K
Retained Earnings $-349.96M $-293.74M $-238.98M $-198.71M $-157.02M $-116.77M $-71.39M $-45.01M $-34.43M -
Total Stockholders Equity $509.77M $534.13M $583.58M $632.98M $622.78M $444.81M $430.27M $269.30M $246.34M $155.03M
Total Liabilities & Equity $1.24B $1.26B $1.27B $1.39B $1.26B $1.10B $884.93M $636.10M $474.57M $227.32M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
Net Income $-6.88M $-6.88M $6.69M $21.73M $20.00M $18.34M $-2.50M $9.59M $14.56M $-87.00K $-6.35M
Stock-based Compensation $4.50M $4.50M $5.10M $4.24M $4.68M $5.81M $5.32M $3.34M $2.67M $1.80M $1.68M
Operating Cash Flow $120.29M $73.61M $70.05M $68.44M $76.54M $68.97M $34.52M $36.43M $24.83M $12.60M $-2.72M
Acquisitions - - - - - - $5.09M - - - -
Investing Cash Flow $-154.08M $-60.40M $-45.94M $67.62M $-137.25M $-194.66M $-223.67M $-258.20M $-151.62M $-252.65M $-150.36M
Debt Repayment - - - - - - - - - - $10.00M
Stock Issued - - $10.90M - $9.90M $205.52M $53.09M $189.50M $37.31M $33.80M $137.29M
Stock Repurchased - $6.00M - - - - - - - - -
Dividends Paid $10.19M $5.82M $5.82M $5.82M $5.82M $5.82M $5.82M $5.82M $5.82M $745.00K $3.88M
Financing Cash Flow $35.66M $-10.26M $-21.89M $-143.79M $62.41M $127.70M $192.72M $224.11M $124.51M $226.56M $163.57M
Net Change in Cash $1.88M $2.95M $2.22M $-7.73M $1.70M $2.01M $3.57M $2.34M $-2.27M $-13.50M $10.98M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $37.23M $34.26M $109.82M $103.62M
Interest Expense $8.18M $7.24M $22.19M $19.52M
Net Income $-5.06M $3.39M $-736.00K $3.75M
Basic EPS -0.45 0.14 -0.35 -0.04
Diluted EPS -0.45 0.14 -0.35 -0.04
Basic Shares Outstanding $13.39M $13.15M $13.38M $13.13M
Diluted Shares Outstanding $13.39M $13.15M $13.38M $13.13M
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $7.12M $6.82M
Accounts Receivable $7.95M $7.42M
Goodwill $5.90M $5.90M
Total Assets $1.27B $1.26B
Total Liabilities $767.41M $700.57M
Common Stock $13.00K $13.00K
Retained Earnings $-332.57M $-293.74M
Total Stockholders Equity $485.29M $534.13M
Total Liabilities & Equity $1.27B $1.26B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-5.06M $3.39M $-736.00K $3.75M
Stock-based Compensation $1.21M $1.27M $3.09M $3.83M
Operating Cash Flow - - $51.98M $49.52M
Investing Cash Flow - - $-67.15M $-26.42M
Stock Issued - - - $10.90M
Dividends Paid - - $4.37M $4.37M
Financing Cash Flow - - $16.07M $-22.04M
Net Change in Cash - - $898.00K $1.06M

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...